Dana Farber Taps CLC Bio Platform for NGS Data Analysis

Dana Farber's computational biology core selected CLC Bio's platform to keep up with the demand for next-generation sequence data analysis, a spokesperson said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.